开发一种基托基酸反应性粘膜粘合性mRNA疫苗,用于引起粘膜和全身免疫力
Yang Zhou1, Ying Jiang2, Ye Wu2
1School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
设计了一种对酸反应的mRNA疫苗 (PQOm) 以获得强大的粘膜和全身免疫力. 这种新型疫苗增强了抗原递送和免疫反应,显示了预防病毒感染的高潜力.
科学领域:
- 生物技术是生物技术.
- 疫苗学 疫苗学 疫苗学
- 材料科学 材料科学 材料科学
背景情况:
- 粘膜mRNA疫苗提供了一种有前途的预防感染策略,通过在病原体进入部位创建免疫屏障来预防感染.
- 目前的挑战包括快速清除,低抗原活性和低效的mRNA转染,限制了它们的有效性.
研究的目的:
- 设计一种对酸反应的mRNA疫苗 (PQOm),克服当前粘膜mRNA疫苗的局限性.
- 通过改善抗原递送和持续的免疫刺激来增强粘膜和全身免疫反应.
主要方法:
- 使用希夫基聚合物开发PQOm:四分化奇托 (QCS),低分子量聚乙烯胺和化功能化聚乙烯糖醇.
- 研究固体阻碍对mRNA转染效率的影响.
- 对酸反应性mRNA释放和转染能力的评估.
- 评估PQOm对鼻腔粘膜的附着性和刺激与鼻相关的淋巴组织 (NALT).
主要成果:
- PQOm证明了高效的mRNA转染和响应酸的释放.
- 疫苗在鼻腔粘膜上粘附了长达6天,提供了持续的NALT刺激.
- PQOm引发了强大的粘膜和全身免疫反应,解决了对抗原的低NALT反应性.
- 没有观察到显著的毒性.
结论:
- PQOm代表了一个有前途的粘膜mRNA疫苗候选人.
- 这种工程疫苗有效地刺激了强大的免疫反应,并且在预防病毒感染方面具有很高的临床潜力.
更多相关视频
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
相关概念视频
Vaccinations
Humoral Immune Responses
Lewis Acids and Bases
A coordinate covalent bond (or dative bond) occurs when one of the atoms in the bond provides both bonding electrons. For example, a coordinate covalent bond occurs when a water molecule combines with a hydrogen ion to form a hydronium ion. A coordinate covalent bond also results when...
Ions as Acids and Bases
Salts are ionic compounds composed of cations and anions, either of which may be capable of undergoing an acid or base ionization reaction with water. Aqueous salt solutions, therefore, may be acidic, basic, or neutral, depending on the relative acid-base strengths of the salt’s constituent ions. For example, dissolving the ammonium chloride in water results in its dissociation, as described by the equation:
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
